Encapsulated faecal microbiota transfer to target immune activation in patients with cirrhosis and ascites (TransImmune): protocol for a randomised, double-blind, Phase IIa, placebo-controlled trial / Karsten Große, Frederic Haedge, Carmen Fera, Jana Hecker, Jan Wienstroer, Anastasia Tsakmaklis, Andreas Fichtner, Nicole S. Treichel, Thomas Clavel, Theresa Wirtz, Oliver Pabst, Rainer Schuckelt, Maria JGT Vehreschild, Tony Bruns

Related documents

• Extracorporeal Albumin Dialysis (OPAL) as novel therapeutic bridging option in posthepatectomy liver failure#661859
• An in vitro analysis of two-body wear and three body wear, hardness, and degree of conversion of 3D-printed restorative materials#661862
• Real-world data on the impact of dose reduction measures on radiation exposure in CT perfusion of the brain#661864
• Ecotoxic and genotoxic potential of eluates from dental composite dust - an in vitro study#661865
• Multicenter end-to-end evaluation of single-isocenter multitarget stereotactic radiosurgery approaches: accuracy and plan quality#661866